These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 18097026)

  • 1. Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis.
    Shalev I; Liu H; Koscik C; Bartczak A; Javadi M; Wong KM; Maknojia A; He W; Liu MF; Diao J; Winter E; Manuel J; McCarthy D; Cattral M; Gommerman J; Clark DA; Phillips MJ; Gorczynski RR; Zhang L; Downey G; Grant D; Cybulsky MI; Levy G
    J Immunol; 2008 Jan; 180(1):249-60. PubMed ID: 18097026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of Fibrinogen-like Protein 2 (FGL-2), a Novel CD4+ CD25+ Treg Effector Molecule, Leads to Improved Control of Echinococcus multilocularis Infection in Mice.
    Wang J; Vuitton DA; Müller N; Hemphill A; Spiliotis M; Blagosklonov O; Grandgirard D; Leib SL; Shalev I; Levy G; Lu X; Lin R; Wen H; Gottstein B
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003755. PubMed ID: 25955764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted deletion of FGL2 leads to increased early viral replication and enhanced adaptive immunity in a murine model of acute viral hepatitis caused by LCMV WE.
    Khattar R; Luft O; Yavorska N; Shalev I; Phillips MJ; Adeyi O; Gao D; Bartczak A; Urbanellis P; Shyu W; Zhang J; Manuel J; Levy GA; Selzner N
    PLoS One; 2013; 8(10):e72309. PubMed ID: 24146739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the Fibrinogen-Like Protein 2:FcγRIIB/RIII immunosuppressive pathway enhances antiviral T-cell and B-cell responses leading to clearance of lymphocytic choriomeningitis virus clone 13.
    Luft O; Khattar R; Farrokhi K; Ferri D; Yavorska N; Zhang J; Sadozai H; Adeyi O; Chruscinski A; Levy GA; Selzner N
    Immunology; 2018 Jul; 154(3):476-489. PubMed ID: 29341118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble fibrinogen-like protein 2/fibroleukin exhibits immunosuppressive properties: suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells.
    Chan CW; Kay LS; Khadaroo RG; Chan MW; Lakatoo S; Young KJ; Zhang L; Gorczynski RM; Cattral M; Rotstein O; Levy GA
    J Immunol; 2003 Apr; 170(8):4036-44. PubMed ID: 12682232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T Follicular Regulatory Cell-Derived Fibrinogen-like Protein 2 Regulates Production of Autoantibodies and Induction of Systemic Autoimmunity.
    Sungnak W; Wagner A; Kowalczyk MS; Bod L; Kye YC; Sage PT; Sharpe AH; Sobel RA; Quintana FJ; Rozenblatt-Rosen O; Regev A; Wang C; Yosef N; Kuchroo VK
    J Immunol; 2020 Dec; 205(12):3247-3262. PubMed ID: 33168576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A homozygous truncating mutation of FGL2 is associated with immune dysregulation.
    Janssen E; Alosaimi MF; Alazami AM; Alsuliman A; Alaiya A; Al-Saud B; Al-Mousa H; Al-Zaid TJ; Smith E; Platt CD; Alruwaili H; Albanyan S; Al-Mayouf SM; Geha RS
    J Allergy Clin Immunol; 2023 Feb; 151(2):572-578.e1. PubMed ID: 36243222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis.
    Shalev I; Wong KM; Foerster K; Zhu Y; Chan C; Maknojia A; Zhang J; Ma XZ; Yang XC; Gao JF; Liu H; Selzner N; Clark DA; Adeyi O; Phillips MJ; Gorczynski RR; Grant D; McGilvray I; Levy G
    Hepatology; 2009 Feb; 49(2):387-97. PubMed ID: 19085958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of fibrinogen-like protein 2 protects against T cell-induced colitis.
    Bartczak A; Zhang J; Adeyi O; Amir A; Grant D; Gorczynski R; Selzner N; Chruscinski A; Levy GA
    World J Gastroenterol; 2017 Apr; 23(15):2673-2684. PubMed ID: 28487604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The FGL2-FcgammaRIIB pathway: a novel mechanism leading to immunosuppression.
    Liu H; Shalev I; Manuel J; He W; Leung E; Crookshank J; Liu MF; Diao J; Cattral M; Clark DA; Isenman DE; Gorczynski RM; Grant DR; Zhang L; Phillips MJ; Cybulsky MI; Levy GA
    Eur J Immunol; 2008 Nov; 38(11):3114-26. PubMed ID: 18991288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Regulatory T Cells (Treg) and the Treg Effector Molecule Fibrinogen-like Protein 2 in Alloimmunity and Autoimmunity.
    Chruscinski A; Sadozai H; Rojas-Luengas V; Bartczak A; Khattar R; Selzner N; Levy GA
    Rambam Maimonides Med J; 2015 Jul; 6(3):. PubMed ID: 26241231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.
    Yan J; Kong LY; Hu J; Gabrusiewicz K; Dibra D; Xia X; Heimberger AB; Li S
    J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 25971300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FcγRIIB regulates T-cell autoreactivity, ANCA production, and neutrophil activation to suppress anti-myeloperoxidase glomerulonephritis.
    Ooi JD; Gan PY; Chen T; Eggenhuizen PJ; Chang J; Alikhan MA; Odobasic D; Holdsworth SR; Kitching AR
    Kidney Int; 2014 Dec; 86(6):1140-9. PubMed ID: 24869670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGL2 promotes tumor progression in the CNS by suppressing CD103
    Yan J; Zhao Q; Gabrusiewicz K; Kong LY; Xia X; Wang J; Ott M; Xu J; Davis RE; Huo L; Rao G; Sun SC; Watowich SS; Heimberger AB; Li S
    Nat Commun; 2019 Jan; 10(1):448. PubMed ID: 30683885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated fibrinogen‑like protein 2 in TNBS‑induced colitis mice: Association with Th17 and regulatory T cells.
    Lin H; Chen R; Jiang X; Wu X; Huang X; Dong X; Yang X; Lin X; Chen X; Chen X; Huang Z
    Mol Med Rep; 2017 Sep; 16(3):3445-3454. PubMed ID: 28713999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGL2/fibroleukin mediates hepatic reperfusion injury by induction of sinusoidal endothelial cell and hepatocyte apoptosis in mice.
    Selzner N; Liu H; Boehnert MU; Adeyi OA; Shalev I; Bartczak AM; Xue-Zhong M; Manuel J; Rotstein OD; McGilvray ID; Grant DR; Phillips MJ; Levy GA; Selzner M
    J Hepatol; 2012 Jan; 56(1):153-9. PubMed ID: 21756857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Foxp3(+) Treg cell activity reduces dendritic cell co-stimulatory molecule expression in aged mice.
    Chiu BC; Stolberg VR; Zhang H; Chensue SW
    Mech Ageing Dev; 2007; 128(11-12):618-27. PubMed ID: 17961632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential development of CD4 and CD8 T regulatory cells in RasGRP1-deficient mice.
    Chen X; Priatel JJ; Chow MT; Teh HS
    J Immunol; 2008 May; 180(9):5973-82. PubMed ID: 18424717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of fibrinogen-like protein 2 (FGL2): monomeric FGL2 has enhanced immunosuppressive activity in comparison to oligomeric FGL2.
    Liu H; Yang PS; Zhu T; Manuel J; Zhang J; He W; Shalev I; Zhang L; Cybulsky MI; Grant DR; Phillips MJ; Levy GA
    Int J Biochem Cell Biol; 2013 Feb; 45(2):408-18. PubMed ID: 23127799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin-modified dendritic cells in vitro ameliorate experimental autoimmune myasthenia gravis by up-regulated Treg cells and shifted Th1/Th17 to Th2 cytokines.
    Li XL; Liu Y; Cao LL; Li H; Yue LT; Wang S; Zhang M; Li XH; Dou YC; Duan RS
    Mol Cell Neurosci; 2013 Sep; 56():85-95. PubMed ID: 23541702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.